All HLB group stocks finished lower across the domestic market on the 21st. With the KOSDAQ market plunging more than 4%, shares of HLB and its major affiliates showed weakness together heading into the weekend.

In the regular session on the 21st, HLB closed at 38,400 won, down 3.75% from the previous trading day. Other group stocks also failed to escape the downward trend.

The stocks with relatively larger declines were HLB Therapeutics and HLB Innovation. HLB Therapeutics plunged 6.65% to 2,105 won, while HLB Innovation finished trading at 13,890 won, down 5.64%.

Declines in the remaining stocks were relatively limited. HLB Pharmaceutical closed 3.32% lower at 7,860 won, and HLB Life Science ended 3.13% down at 2,940 won. HLB Life Science at one point fell to 2,860 won during the session. HLB PEP closed down 3.02% at 4,650 won, HLB Panagen fell 2.99% to 1,133 won, HLB Genex dropped 2.29% to 1,876 won, and HLB Biostep finished 1.87% lower at 2,350 won. HLB Global closed 0.18% down at 1,577 won.

The simultaneous weakness of HLB group stocks came in tandem with the broader slump in the KOSDAQ market. On the 21st, the KOSDAQ index closed at 801.94, down 38.95 points (4.63%) from the previous trading day, and investor sentiment was badly shaken, with a sell-side sidecar even being triggered intraday.

Attention is now focused on whether HLB group stocks can turn the tide in the new trading week after the weekend. With the KOSDAQ index pushed down near the 800 level, the group's stock price trend centered on HLB will be worth watching, along with whether overall market investor sentiment can recover.